GE HealthCare
GEHC · NASDAQ · Healthcare
$64.13
$0.31 (-0.49%) today
Market Cap
$29.17B
24h Volume
$487.4M
P/E Ratio
14.8
52w High
$88.03
52w Low
$59.45
Est. AI Revenue
10%
7-Day Sparkline (Static)
Company facts
Performance
About GE HealthCare
GE HealthCare makes medical imaging equipment, patient monitoring systems, and diagnostic agents sold to hospitals and health systems worldwide. It earns revenue from equipment sales, long-term service contracts, and software subscriptions across four segments: imaging, ultrasound, patient care solutions, and pharmaceutical diagnostics.
The company holds more FDA authorizations for AI-enabled medical devices than any other manufacturer. AIR Recon DL and TrueFidelity use deep learning to reconstruct sharper MRI and CT images from faster scans, while Command Center software applies AI to hospital operations and patient flow. It is also partnering with NVIDIA on autonomous imaging systems.
GE HealthCare traces its roots to 1994 as part of General Electric and became an independent company in 2023. Headquartered in Chicago, Illinois, it employs about 54,000 people and trades on the NASDAQ.
GE HealthCare in the AI buildout
GE HealthCare anchors the AI Healthcare layer. Its scanners and monitors are the hardware where clinical AI reaches patients, and its deep learning reconstruction software shows how AI features increasingly sell the underlying machines. As hospitals adopt AI-enabled imaging, the company benefits through premium equipment, software subscriptions, and its NVIDIA collaboration on autonomous imaging. Its exposure grows as AI shifts from a differentiator to a requirement in medical devices, even though the core business remains hardware and services.
GEHC is tracked in AI Healthcare, rated Growing on the AI Exposure leaderboard.
By the numbers
52-week range
GEHC trades at $64.13, 16% of the way up its 52-week range of $59.45 to $88.03.
Market cap
Market capitalization is $29.17B, with an AI Exposure Score of 42 out of 100.
Valuation vs peers
Its P/E ratio of 14.8 is below the AI Healthcare category median of 29.6.
Next earnings
GE HealthCare is next expected to report earnings on October 28, 2026.
Market data as of the close on . Prices are end of day, not live.
Frequently asked questions
What does GE HealthCare do?
GE HealthCare makes medical imaging machines, ultrasound systems, patient monitors, and diagnostic agents for hospitals worldwide. It earns money from equipment sales, service contracts, and software, and became an independent company in 2023 after separating from General Electric.
How is GE HealthCare exposed to AI?
Supercycle rates GE HealthCare as Growing with an AI Exposure Score of 42 out of 100. It leads all companies in FDA authorizations for AI-enabled devices, but most revenue still comes from imaging hardware and services rather than AI itself.
What are GE HealthCare's main AI products?
AIR Recon DL applies deep learning to MRI reconstruction, producing sharper images from faster scans. TrueFidelity does the same for CT. Command Center software uses AI to manage hospital operations, and an NVIDIA partnership targets autonomous imaging systems.
Who leads GE HealthCare?
Peter Arduini has served as president and chief executive since the company prepared for its 2023 spin-off from General Electric. He leads a workforce of about 54,000 people from the company's Chicago headquarters.
Is GEHC a pure play AI stock?
No. GE HealthCare is a Growing tier stock. AI features increasingly differentiate its scanners and software, but the business is fundamentally medical equipment and services sold to hospitals, not a company that exists because of AI demand.
Profile written 2026-08, updated as the business changes. Editorial content, not investment advice.